Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Alex A Adjei


United States of America

Mayo Clinic
Rochester, MN

Alex A. Adjei is Professor of Oncology and Professor of Pharmacology in the Mayo College of Medicine. He is also a consultant in Medical Oncology at Mayo Clinic.  Dr Adjei is Director of the Early Cancer Therapeutics Program across all three Mayo Clinic sites, and leader of the Lung Cancer Program across all 3 Mayo Clinic sites.

He is the Principal Investigator of the Mayo Phase I and Phase II NCI grants.

Dr Adjei has served on a number of National Cancer Institute Committees.

He is currently co-chair of the Thoracic Malignancies Steering Committee.

He is the Editor-in-Chief of the Journal of Thoracic Oncology.

Dr Adjei’s research is focused on experimental therapeutics and clinical drug development.

He received the first ASCO Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development.

He has authored 260 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapeutics/phase II trials of lung cancer.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings